M&A

  • People put paper ballots into an election box.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    AMS secures shareholder support for planned sale to H.B. Fuller

    Buying tissue-healing company AMS will bring H.B. Fuller into the markets for formulated biosurgicals and mechanical closures.

    By • Updated Aug. 14, 2026
  • Scientists working in Laboratory for visual analyze the sample in petri dish.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Thermo Fisher closes $1.1B sale of microbiology unit to PE firm

    European private equity firm Astorg will run the business as an independent diagnostics company, led by former PerkinElmer CEO Dirk Bontridder.

    By • Aug. 13, 2026
  • An x-ray image of the ankle and foot.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Teledyne inks $1.1B takeover of Varex Imaging

    Buying Varex will increase Teledyne’s exposure to the healthcare market. Teledyne said the companies’ imaging technologies complement each other with minimal overlap.

    By • Aug. 11, 2026
  • A white, rounded hourglass-shaped patch says "vitalconnect"
    Image attribution tooltip
    Courtesy of VitalConnect
    Image attribution tooltip

    IRhythm grows heart monitoring leadership with $288M VitalConnect buy

    Acquiring VitalConnect could unlock a $1 billion cardiac monitoring market that is only partly served by iRhythm’s existing devices.

    By • Aug. 10, 2026
  • A white sign in front of a brick and glass building says "Integer."
    Image attribution tooltip
    Retrieved from Integer Holdings on August 03, 2026
    Image attribution tooltip

    KKR to take Integer private for $5.7B

    Integer expects to gain flexibility and capital to invest in its contract development and manufacturing business under KKR.

    By • Aug. 3, 2026
  • Two people in suits shake hands.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Cardinal inks 2 acquisitions in bid to expand at-home services

    The company agreed to buy a diabetes health business and medical supplier Strive Medical to boost its growing in-home solutions unit.

    By Sydney Halleman • July 22, 2026
  • A person wearing a blue glove holds a test tube with red liquid
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Tempus to buy cancer test maker Personalis for $1.5B

    Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.

    By • July 20, 2026
  • A modern two-story commercial office building with a mix of gray and wood paneling on the exterior. Large glass windows dominate both floors, and the front entrance features the "Medtronic" logo above double glass doors. The surrounding area includes a few small shrubs and empty parking spaces in front.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Medtronic completes SPR Therapeutics acquisition

    Medtronic bought the pain company to expand in neuromodulation, one of its areas of strategic focus and investment.

    By • July 17, 2026
  • Three gray, rectangular devices are pictured next to each other.
    Image attribution tooltip
    Courtesy of Expanding Innovations
    Image attribution tooltip

    DePuy Synthes adds spine implants with Expanding Innovations buy

    DePuy expects the technology, which doesn’t use screws, will strengthen its spine business and integrate into its Velys portfolio.

    By • July 16, 2026
  • An image of a robotic surgery system.
    Image attribution tooltip
    Permission granted by Stereotaxis
    Image attribution tooltip

    Stereotaxis closes Robocath takeover

    With the acquisition of Robocath completed, Stereotaxis intends to accelerate development of next-generation robotic technologies for endovascular procedures.

    By • July 9, 2026
  • A CPAP device, lamp and smartphone sit on a nightstand.
    Image attribution tooltip
    Courtesy of Resmed
    Image attribution tooltip

    Resmed to sell MatrixCare for $490M to private equity firm

    Selling the software business to Frazier Healthcare Partners will allow the respiratory device maker to shift more resources to faster-growing parts of its portfolio.

    By • July 8, 2026
  • Boston Scientific's headquarters building is shown.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Top 10 medtech deals in the first half of 2026

    Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding quickly.

    By • July 6, 2026
  • A sign for Zimmer Biomet is shown outside of the company's headquarters building.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Zimmer to buy Pacira pain relief device for up to $140M

    Pacira’s iovera device uses cold therapy for targeted pain relief. An analyst said the addition complements Zimmer Biomet’s portfolio.

    By • June 30, 2026
  • A sign announces the company name at Agilent's headquarters building in Santa Clara, California.
    Image attribution tooltip
    Permission granted by Agilent
    Image attribution tooltip

    Agilent finalizes Biocare Medical takeover

    The acquisition strengthens Agilent’s presence in areas including cancer and infectious disease diagnostic and research markets.

    By • June 26, 2026
  • An image of a surgeon and another clinician in blue scrubs working with a surgical robot.
    Image attribution tooltip
    Courtesy of Karl Storz
    Image attribution tooltip

    Karl Storz laying off employees in North Carolina amid robotics strategy shift

    The cuts come as Karl Storz plans to retire the Asensus brand and the Senhance robot as part of organizational changes.

    By • June 22, 2026
  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Medtech M&A maintains momentum following decade-high 2025: PwC

    Deal volumes and values are tracking above the first half of 2025, driven by Boston Scientific’s Penumbra buyout and Danaher’s Masimo acquisition.

    By • June 17, 2026
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic closes Scientia Vascular takeover, continuing M&A streak

    CEO Geoff Martha said the acquisition will enable “every neurovascular procedure to start with Medtronic.”

    By • June 15, 2026
  • Illustration of a blood clot blocking red blood cells within an artery or a vein.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Penumbra’s FDA nod for clot removal tech a win for Boston Scientific

    The stroke treatment could contribute about $100 million in incremental revenue over time to Boston Scientific, the buyer of Penumbra, one analyst said.

    By • June 12, 2026
  • A picture of Masimo's headquarters building.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Danaher closes $9.9B Masimo buyout

    CEO Rainer Blair said Danaher has the money and “leadership bandwidth” to strike further deals across any of its three business areas.

    By • June 11, 2026
  • A person sits in a white chair and looks to the side.
    Image attribution tooltip
    Elise Reuter/MedTech Dive, data from MedTech Dive
    Image attribution tooltip

    Resmed completes $340M Noctrix takeover

    The buyout gives Resmed control of a noninvasive treatment for restless legs syndrome.

    By • June 2, 2026
  • Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    J&J’s DePuy Synthes inks deal to buy orthopedic surgery tech

    The acquisition is the latest in a series of agreements between DePuy Synthes and organizations associated with entrepreneur Stéphane Lavallée.

    By • May 27, 2026
  • BioProtect's balloon spacer is shown against a white background.
    Image attribution tooltip
    Courtesy of Olympus
    Image attribution tooltip

    Olympus expands in cancer tech with $270M buy of BioProtect

    BioProtect’s balloon spacer device separates the prostate from other structures during cancer radiation.

    By • May 26, 2026
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic to buy SPR Therapeutics for about $650M

    Medtronic would gain a treatment for chronic pain management in its third major acquisition this year.

    By • May 20, 2026
  • Illustration of a blood clot blocking red blood cells within an artery or a vein.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Endologix buys clot removal system from Surmodics

    Endologix will market the system to vascular interventionists who use its other devices to treat peripheral artery disease and abdominal aortic aneurysms.

    By • May 20, 2026
  • An anatomical heart is pictured in red in a transparent body.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Artivion closes Endospan buyout to acquire recently approved heart device

    Artivion is targeting a $150 million annual U.S. market for the Nexus Aortic Arch System.

    By • May 19, 2026